Sfoglia per AUTORE
VITOLO U
Collezione ASL Biella

  

Items : 10

End of induction [(18)F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial. in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3311-3321. doi: 10.1007/s00259-024-06765-z. Epub 2024 Ma

2024
ASL Biella
AOU Alessandria

Versari A; Luminari S; Pennese E; Perrone T; Liberati AM; Stefani PM; Ibatici A; Usai SV; Falcinelli F; Vitolo U; Gini G; Roti G; Galimberti S; Musto P; Mannina D; Conconi A; Bari A; Massaia M; Califano C; Chiarenza A; Arcari A; Pavone V; Bianchi B; Bolis SAM; Musuraca G; Tosi P; Barbieri E; Ladetto M; Monaco L; et alii...

IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma. in Blood advances / Blood Adv. 2024 Mar 26;8(6):1541-1549. doi: 10.1182/bloodadvances.2023011251.

2024
ASL Biella
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Zucca E; Pisani F; Pinotti G; Dore F; Esposito F; Pirosa MC; Cesaretti M; Bonomini L; Vitolo U; Zanni M; Ghiggi C; Celli M; Annibali O; Liberati AM; Cabras MG; Orsucci L; Bruna R; Gaidano G; Balzarotti M; Merli F; Tucci A; Vanazzi A; Sassone M; Ferreri AJM; Botto B; Stathis A; Chiappella A; Tani M; Conconi A; et alii...

Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi. in Hematological oncology / Hematol Oncol. 2023 Oct;41(4):655-662. doi: 10.1002/hon.3184. Epub 2023 May 28.

2023
AO Cuneo
ASL Biella

Gini G; Federico M; Luminari S; Marcheselli L; Catellani H; Skrypets T; Stefani PM; Pastore D; Pennese E; Liberati AM; Ballerini F; Vitolo U; Usai SV; Capponi M; Galimberti S; Perrone T; Re F; Mannina D; Musto P; Conconi A; Bari A; Massaia M; Ghiggi C; Pulsoni A; Musuraca G; Califano C; Merli M; Manni M; Nizzoli ME; et alii...

Rituximab and Lenalidomide (R 2) Vs Rituximab Alone As Maintenance Treatment after Chemoimmunotherapy for Elderly Patients with Relapsed/Refractory Follicular Lymphoma (FL): Final Analysis of Renoir Phase III Study of the Fondazione Italiana Linfomi (FIL) in Blood

2023
ASL Biella

Boccomini C; Botto B; Evangelista A; Zilioli VR; Anastasia A; Cavallo F; Merli F; Zanni M; Tani M; Chiarenza A; Liberati AM; Conconi A; Corradini P; Bari A; Annechini G; Gaidano G; Spina M; Sartori R; Castellino C; Puccini B; Arcari A; Bigliardi S; Matta G; Merli M; Mannina D; Marino D; Galieni P; Ciambelli F; Musuraca G; et alii...

Treatment of Relapsed/Refractory Waldenström Macroglobulinemia Patients: Final Clinical and Molecular Results of the Phase II Brb (Bendamustine, Rituximab and Bortezomib) Trial of the Fondazione Italiana Linfomi (FIL) in Blood

2021
AOU Città della Salute di Torino
ASL Biella

Benevolo G; Ferrero S; Villivà N; Castiglione A; Monaco F; Boccomini C; Cabras MG; Califano C; Casula P; Cavallo F; Conconi A; Drandi D; Gaidano G; Gregorini AI; Felici S; Ferrante M; Mannina D; Molinari AL; Musto P; Musuraca G; Merli M; Sartori R; Tani M; Varettoni M; Vitolo U; Orsucci L;

The role of central nervous system prophylaxis and contralateral testis radiotherapy in primary testicular lymphoma: Long term analysis of the phase II IELSG10 study and preliminary results of the IELSG30 study of international extranodal lymphoma study group and fondazione Italiana linfomi in Haematologica

2019
ASL Biella

Chiappella A; Zucca E; Ferreri AJM; Ciccone G; Vanazzi A; Martelli M; Tucci A; Balzarotti M; Merli F; Cabras MG; Nassi L; Pavone V; Storti S; Tani M; Molinari AL; Conconi A; Gomez H; Lopez-Guillermo A; Sarris AH; Ricardi U; Gospodarowicz MK; Cavalli F; Vitolo U;

Clinical and molecular results of the phase II BRB (bendamustine, rituximab and bortezomib) trial of the fondazione italiana linfomi (FIL) for relapsed/refractory waldenström macroglobulinemia patients in Blood

2018
ASL Biella
AOU Città della Salute di Torino

Benevolo G; Ferrero S; Andriani A; Castiglione A; Baraldi A; Boccomini C; Cabras MG; Califano C; Cavallo F; Conconi A; Curreli L; Drandi D; Gaidano G; Felici S; Ferrante M; Mannina D; Merli M; Molinari AL; Musto P; Musuraca G; Rossi FG; Sartori R; Tani M; Varettoni M; Vitolo U; Orsucci L;

Myelodysplastic syndromes with hypocellular marrow: Clinical characteristics and evaluation of outcome in HemaSphere

2018
ASL Biella
ASL Città di Torino
ASL Asti
ASL Torino 4
ASL Torino 5
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Alessandria
ASL Novara

Santini V; Gioia D; Masiera E; Poloni A; Ferrero D; Fragasso A; Finelli C; Salvi F; Gaidano G; Oliva EN; Catarini M; Cametti G; Bonferroni M; Danise P; Tassara R; Allione B; Cilloni D; Castelli A; Centurioni R; Ciravegna G; Visani G; Musto P; Balleari E; Biale L; Capelli D; Frairia C; Galimberti S; Giaccone L; Macchi S; et alii...

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Jun 10;35(17):1905-1912. doi: 10.1200/JCO.2016.70.6994. Epub 2017 Mar 29.

2017
ASL Biella
AOU Città della Salute di Torino

Thieblemont C; Johnson P; Cavalli F; Mazzucchelli L; Campo E; Jack A; Moreau A; Ponzoni M; Bellei M; Stelitano C; Haioun C; Bosly A; Zachée P; Ferreri AJM; Hohaus S; Torri V; Tilly H; Morschhauser F; Devizzi L; Pinotti G; Guillermo AL; Sebban C; Salles G; Pettengell R; Martelli M; Vitolo U; Tucci A; Martinelli G; Bouabdallah R; et alii...

Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group. in British journal of haematology / Br J Haematol. 2014 Jul;166(1):69-76. doi: 10.1111/bjh.12845. Epub 2014 Mar 27.

2014
ASL Biella
AOU Novara

Zucca E; Cavalli F; Gaidano G; Stathis A; Porro E; Kiesewetter B; Vitolo U; Martinelli G; Zinzani PL; Arcaini L; Magagnoli M; Ferreri AJ; Devizzi L; Conconi A; Raderer M; Franceschetti S;